Back to Search
Start Over
Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.
- Source :
-
British journal of cancer [Br J Cancer] 2001 Jul 06; Vol. 85 (1), pp. 1-8. - Publication Year :
- 2001
-
Abstract
- The authors updated their report on a randomized trial initiated in 1982 comparing, in early breast cancer, high-dose IM Medroxyprogesterone acetate (HD-MPA) adjuvant hormonotherapy during 6 months with no hormonotherapy; node-positive patients also received 6 courses of IV CMF (day 1, day 8; q.4 weeks). 246 node-negative (NN) and 270 node-positive (NP) patients had been followed for a median duration of 13 years. Previous results were confirmed in this analysis on mature data. In NN patients, relapse-free survival (RFS) was improved in the adjuvant hormonotherapy arm, regardless of age while overall survival (OAS) was also increased in younger (less then 50 years) patients. In the whole group of NP patients, no difference was seen regarding RFS or OAS. However, an age-dependant opposite effect was observed: younger patients (< 50) experienced a worse and significant outcome of relapse-free and overall survivals when receiving adjuvant HD-MPA while older patients (> or = 50) enjoyed a significant improvement of their relapse-free survival. For both NN and NP patients, differences in overall survivals observed in older women with a shorter follow-up, were no longer detected.<br /> (Copyright 2001 Cancer Research Campaign.)
- Subjects :
- Age Factors
Analysis of Variance
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Breast Neoplasms pathology
Breast Neoplasms surgery
Chemotherapy, Adjuvant
Cyclophosphamide administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Fluorouracil administration & dosage
Follow-Up Studies
Humans
Injections, Intramuscular
Methotrexate administration & dosage
Middle Aged
Neoplasm Staging
Survival Rate
Treatment Outcome
Antineoplastic Agents, Hormonal therapeutic use
Breast Neoplasms drug therapy
Medroxyprogesterone Acetate therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0007-0920
- Volume :
- 85
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- British journal of cancer
- Publication Type :
- Academic Journal
- Accession number :
- 11437394
- Full Text :
- https://doi.org/10.1054/bjoc.2001.1829